ID   BARD1_RAT               Reviewed;         768 AA.
AC   Q9QZH2;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   24-JUL-2024, entry version 166.
DE   RecName: Full=BRCA1-associated RING domain protein 1;
DE            Short=BARD-1;
DE            EC=2.3.2.27 {ECO:0000250|UniProtKB:Q99728};
DE   AltName: Full=RING-type E3 ubiquitin transferase BARD1 {ECO:0000305};
GN   Name=Bard1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Carcinoma;
RX   PubMed=11156388;
RA   Gautier F., Irminger-Finger I., Gregoire M., Meflah K., Harb J.;
RT   "Identification of an apoptotic cleavage product of BARD1 as an
RT   autoantigen: a potential factor in the antitumoral response mediated by
RT   apoptotic bodies.";
RL   Cancer Res. 60:6895-6900(2000).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase. The BRCA1-BARD1 heterodimer
CC       specifically mediates the formation of 'Lys-6'-linked polyubiquitin
CC       chains and coordinates a diverse range of cellular pathways such as DNA
CC       damage repair, ubiquitination and transcriptional regulation to
CC       maintain genomic stability. Plays a central role in the control of the
CC       cell cycle in response to DNA damage. Acts by mediating ubiquitin E3
CC       ligase activity that is required for its tumor suppressor function.
CC       Also forms a heterodimer with CSTF1/CSTF-50 to modulate mRNA processing
CC       and RNAP II stability by inhibiting pre-mRNA 3' cleavage.
CC       {ECO:0000250|UniProtKB:Q99728}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000250|UniProtKB:Q99728};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Homo- and heterodimer. Heterodimer (RING-type zinc finger)
CC       with BRCA1. Heterodimer (via ANK repeats and BRCT domains) with
CC       CSTF1/CSTF-50. Component of the BRCA1-A complex, at least composed of
CC       the BRCA1, BARD1, UIMC1/RAP80, ABRAXAS1, BRCC3/BRCC36, BABAM2 and
CC       BABAM1/NBA1. Interacts with UBXN1. {ECO:0000250|UniProtKB:Q99728}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O70445}. Cytoplasm
CC       {ECO:0000250|UniProtKB:O70445}. Note=Can translocate to the cytoplasm.
CC       Localizes at sites of DNA damage at double-strand breaks (DSBs);
CC       recruitment to DNA damage sites is mediated by the BRCA1-A complex.
CC       {ECO:0000250|UniProtKB:Q99728}.
CC   -!- PTM: Processed during apoptosis. The homodimer is more susceptible to
CC       proteolytic cleavage than the BARD1/BRCA1 heterodimer.
CC       {ECO:0000250|UniProtKB:Q99728}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF182946; AAF00500.1; -; mRNA.
DR   RefSeq; NP_072144.1; NM_022622.1.
DR   AlphaFoldDB; Q9QZH2; -.
DR   SMR; Q9QZH2; -.
DR   STRING; 10116.ENSRNOP00000075183; -.
DR   iPTMnet; Q9QZH2; -.
DR   PhosphoSitePlus; Q9QZH2; -.
DR   PaxDb; 10116-ENSRNOP00000020414; -.
DR   GeneID; 64557; -.
DR   KEGG; rno:64557; -.
DR   UCSC; RGD:621072; rat.
DR   AGR; RGD:621072; -.
DR   CTD; 580; -.
DR   RGD; 621072; Bard1.
DR   eggNOG; KOG0504; Eukaryota.
DR   eggNOG; KOG4362; Eukaryota.
DR   InParanoid; Q9QZH2; -.
DR   PhylomeDB; Q9QZH2; -.
DR   Reactome; R-RNO-5685938; HDR through Single Strand Annealing (SSA).
DR   Reactome; R-RNO-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-RNO-5689603; UCH proteinases.
DR   Reactome; R-RNO-5689901; Metalloprotease DUBs.
DR   Reactome; R-RNO-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-RNO-5693568; Resolution of D-loop Structures through Holliday Junction Intermediates.
DR   Reactome; R-RNO-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-RNO-5693579; Homologous DNA Pairing and Strand Exchange.
DR   Reactome; R-RNO-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-RNO-5693616; Presynaptic phase of homologous DNA pairing and strand exchange.
DR   Reactome; R-RNO-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-RNO-69473; G2/M DNA damage checkpoint.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:Q9QZH2; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0070531; C:BRCA1-A complex; ISO:RGD.
DR   GO; GO:0070532; C:BRCA1-B complex; ISO:RGD.
DR   GO; GO:0031436; C:BRCA1-BARD1 complex; ISS:UniProtKB.
DR   GO; GO:0070533; C:BRCA1-C complex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0000152; C:nuclear ubiquitin ligase complex; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; ISO:RGD.
DR   GO; GO:0016740; F:transferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEP:RGD.
DR   GO; GO:0071479; P:cellular response to ionizing radiation; ISO:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IEP:RGD.
DR   GO; GO:0071394; P:cellular response to testosterone stimulus; IEP:RGD.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0046826; P:negative regulation of protein export from nucleus; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:RGD.
DR   GO; GO:0085020; P:protein K6-linked ubiquitination; ISS:UniProtKB.
DR   GO; GO:0042325; P:regulation of phosphorylation; ISS:UniProtKB.
DR   GO; GO:1904044; P:response to aldosterone; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   CDD; cd17734; BRCT_Bard1_rpt1; 1.
DR   CDD; cd17720; BRCT_Bard1_rpt2; 1.
DR   CDD; cd16496; RING-HC_BARD1; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 1.
DR   Gene3D; 3.40.50.10190; BRCT domain; 2.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR039503; BARD1_Znf-RING.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR036420; BRCT_dom_sf.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR24171; ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 39-RELATED; 1.
DR   PANTHER; PTHR24171:SF8; ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 39-RELATED; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF14835; zf-RING_6; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 3.
DR   SMART; SM00292; BRCT; 2.
DR   SUPFAM; SSF48403; Ankyrin repeat; 1.
DR   SUPFAM; SSF52113; BRCT domain; 2.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
DR   PROSITE; PS50172; BRCT; 2.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   2: Evidence at transcript level;
KW   ANK repeat; Cytoplasm; DNA damage; DNA repair; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Transferase; Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..768
FT                   /note="BRCA1-associated RING domain protein 1"
FT                   /id="PRO_0000055821"
FT   REPEAT          417..449
FT                   /note="ANK 1"
FT   REPEAT          450..482
FT                   /note="ANK 2"
FT   REPEAT          483..515
FT                   /note="ANK 3"
FT   REPEAT          516..536
FT                   /note="ANK 4; degenerate"
FT   DOMAIN          551..644
FT                   /note="BRCT 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          658..768
FT                   /note="BRCT 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   ZN_FING         44..81
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          20..113
FT                   /note="Required for BRCA1 binding"
FT                   /evidence="ECO:0000250"
FT   REGION          188..226
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          307..334
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          370..414
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          544..548
FT                   /note="Flexible linker"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        207..226
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        315..330
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        370..405
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         380
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99728"
FT   MOD_RES         383
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99728"
FT   CROSSLNK        154
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99728"
FT   CROSSLNK        413
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99728"
FT   CROSSLNK        538
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99728"
SQ   SEQUENCE   768 AA;  84548 MW;  9EBB22374910B49A CRC64;
     MPRRPPRVCS GNKPPPVPAM EPATDGLWAH SRAALARLEK LLRCSRCANI LREPVCLGGC
     EHIFCSGCIS DCVGSGCPVC HTPAWILDLK INRQLDSMIQ LYSKLQNLLH DNKGSDSKDD
     TSRASLFGDA ERKKNSVKMW FSPRSKKIRC VVNKVSVQTQ PQKAKDDKAQ EASVFEFVSA
     TPPVVVSTRA KTASRTSAKK HPKKSVAKIN REGNFRPETR DSRFDSKEKL KEEKVVSFSQ
     TLVMENSRVN GEIDLLASGS VVESVFSGSF AEVSLPLAEH IVSPDTVSKS EEAPEKKVCV
     EDRCPVGSDG NPKGCHRPPT STSKKCGSNV PSASGEIREP TLLAENVVLV DCSSLPSGRL
     QVDVTLRRQS NASDDSLSLS PGTPPSLLNN STHRQMMSKP STVKLSSGIP ARKRNHRGET
     LLHIASIKGD ISSVEYLLQN GNDPNVKDHA GWTPLHEACS HGHLKIVELL LQHNALVNTT
     GYHNDSPLHD AAKNGHIDIV KVLLSHGASR NAVNIFGERP VDYTDAENIR SLLLLPEKTD
     SFSTSQCSVQ VNTGQRKSGP LVLIGSGLSS QQQKLLSKLE TVLKAKKCAE FDNTVTHVIV
     PDEEAQSTLK CMLGILNGCW VLKFDWVKAC LDSQEREQEE KYEVPGGPQR SRLNREQLLP
     KLFDGCYFFL GGNFKHHPKE DLLKLIAAAG GRILSRKPKP DSDVTQTINT VAYHAKPDSD
     QRFCTQYIVY EDLFNCHPER VRQGKVWMAP STWLISCVMA FELLPLDS
//
